His brother's pharmacy shares had almost nowhere to go

The situation

Laszlo was standing in the hotel's back office, going through payroll, when his phone buzzed with the accountant's email, and he read it twice before it fully registered that something was wrong. He had just been named executor of his brother Zoltan's estate, and a letter from the accountant who had handled Zoltan's professional corporation for years arrived asking a question Laszlo could not answer: who was going to buy the shares, and had anyone confirmed the buyer was licensed to hold them? Laszlo, who worked as a front-desk supervisor at a hotel in St. Thomas, had never had reason to think about how a pharmacy is actually owned. He assumed the shares were an asset like any other, something the estate could list and sell to whoever offered a fair price, the same way he would have handled a car or a savings account. Nobody had ever explained to him that a professional corporation is not simply a business a family inherits outright. It exists because a regulated profession allows its members to incorporate, and the shares carry restrictions tied to that licence, restrictions that do not disappear just because the licensed person has died.

Zoltan had run an independent pharmacy through a professional corporation for close to two decades. He died suddenly, without much warning, leaving Laszlo to step into an executor's role for an estate more complicated than either of them had planned for. Their relationship had been close but practical, two brothers who saw each other at holidays and helped each other move furniture, not two people who had ever discussed corporate structures.

Laszlo was, at the same time, dealing with a recent diagnosis of his own, a serious illness that meant appointments, treatment planning, and a level of fatigue that made the ordinary demands of an estate feel heavier than they should. He wanted the estate resolved cleanly and did not have the appetite for a drawn-out fight, but he also could not simply ignore what the accountant's letter was telling him: that the shares, likely the single largest asset in an estate otherwise worth somewhere between $300,000 and $600,000, might not be sellable at all in the ordinary way.

The professional regulator that licenses pharmacists in Ontario restricts who can hold shares in a pharmacist's professional corporation to other people licensed in the same profession. It is a rule most people never encounter unless they are the professional themselves or, as Laszlo now found himself, the person responsible for winding up that professional's affairs after death.

The gap nobody had noticed

Zoltan's will, drafted years earlier by a lawyer who was no longer practising, left his estate to Laszlo and made no specific mention of the professional corporation shares at all. They fell into the general residue along with everything else, treated as if they were a bank account or a piece of furniture. Nothing in the will addressed the fact that a professional corporation's shares cannot simply be transferred to whoever inherits under a will if that person is not licensed in the profession. Laszlo was not a pharmacist. Under the regulator's ownership rules, he could not hold the shares himself, even temporarily, beyond whatever limited administrative window the rules allow an estate. Ordinary estate law would normally let an executor hold legal title to almost any asset in trust while sorting out how to distribute or sell it, without needing to personally qualify to own that asset outright. Regulator rules for a professional corporation sit on top of that general principle and are stricter: only someone licensed in the profession can be registered as the shareholder of record, even on an interim basis, which put a real and fairly short clock on how long Laszlo could wait before a sale had to close.

This is the gap that nobody, including Zoltan's original lawyer, had apparently flagged when the will was drafted. A will for a professional with a corporation needs to account for what happens to the shares specifically, because the general default, that everything flows to the residue and the executor sorts it out, runs headfirst into a licensing restriction the executor cannot negotiate around. Zoltan's will treated the corporation like any other asset. The regulator did not.

Making matters harder, when we asked for the corporation's minute book, shareholder agreement, and share certificates to confirm exactly what was being sold and to whom it could be sold, several key documents were missing. Zoltan had apparently kept some records at the pharmacy itself and others at home, and after his death some of the home files had been misplaced during a period when family members were going through his belongings without realizing which papers mattered. There was no shareholder agreement on file at all, which meant there was no contractual mechanism already in place setting out how a sale to a licensed buyer was supposed to work, no formula for valuing the shares, and no first-refusal process among any existing associate pharmacists.

We were starting from close to nothing: a will that did not anticipate the problem, a regulator rule that sharply limited the buyer pool, and a corporate file that had to be rebuilt before we could even say with confidence what the estate actually owned.

What we did

1. Confirmed the regulator's ownership restriction directly with the professional college, rather than relying on general knowledge of professional corporation rules, because the exact scope of who could hold shares and for how long an estate could hold them temporarily needed to be confirmed precisely, in writing, before we advised Laszlo on any timeline he could actually plan around.
2. Reconstructed the corporate file from secondary sources, requesting historical filings from the corporate registry, past tax filings from the accountant, and years of banking records, since the original minute book and share certificates could not be located among Zoltan's papers despite a careful search of both his home and the pharmacy itself.
3. Established the share value using the accountant's historical financial statements in the absence of a formal valuation on file, working through several years of revenue and profit figures with the accountant to give Laszlo a defensible starting number for negotiating with a buyer rather than guessing at what the practice might be worth.
4. Identified the pool of eligible buyers by reaching out, through the accountant and a locum pharmacist who had covered shifts at the pharmacy for years, to licensed pharmacists in the surrounding area who might have an interest in acquiring an established practice with an existing patient base rather than starting one from scratch.
5. Kept the pharmacy operating under a licensed pharmacist's supervision in the interim, arranging for the locum to continue running the day-to-day dispensary under her own licence so the business retained its value and its patients while a permanent buyer was found, rather than closing its doors and losing both.
6. Negotiated with Pratheep, a licensed pharmacist who expressed genuine interest, working within a compressed timeline because the pharmacy could not operate indefinitely on an interim basis and the estate was incurring ongoing rent, staffing and inventory costs the longer the sale process stretched on. We pushed for a decision within weeks rather than months, explaining plainly why the estate could not afford to wait for a stronger offer that might never materialize, and Pratheep agreed to a price that reflected the shortened timeline in exchange for a quicker close on his end too.
7. Drafted a share purchase agreement from scratch, since no template or prior shareholder agreement existed to build from, addressing the licensing condition explicitly so the sale could not close unless Pratheep's licence status was independently confirmed with the regulator at the exact time of transfer. We also built in representations covering the incomplete corporate record, so Pratheep was buying with full knowledge of the gaps rather than discovering them later and using them as grounds to unwind the deal or demand a price reduction after closing.
8. Advised Laszlo on the trade-off between speed and price given both the regulator's restriction on how long the estate could hold the shares and Laszlo's own health situation, which made an extended, drawn-out sale process something he told us plainly he could not realistically sustain. We laid out, in concrete numbers, what waiting longer might gain against what it would cost him in stress and treatment time, so the decision to accept Pratheep's offer was one he made with full information rather than one forced on him by circumstance alone.

The outcome

The sale to Pratheep closed within a few months of Zoltan's death, inside the window the regulator's rules allowed for an estate to hold the shares while a licensed buyer was found. The price reflected a genuine compromise. With more time, a broader search, and a fuller original corporate record, the shares might have drawn stronger interest and a higher offer. Laszlo did not have that time, and the estate did not have the luxury of an open-ended process while it continued paying overhead on a pharmacy with no permanent licensed owner behind it, even with the locum keeping the dispensary open in the meantime.

We describe this as a contained loss rather than a clean win because that is what it was, and Laszlo told us he wanted the file to be described honestly rather than dressed up. The estate recovered meaningful value from the shares, and the sale closed without the pharmacy's licence lapsing or the estate facing a forced closure of the business entirely, but the price landed below what a properly documented, unhurried sale process would likely have achieved with a broader pool of interested buyers and more time to negotiate. Laszlo accepted that trade-off deliberately, weighing it against his own capacity to manage a longer fight while also managing his own treatment schedule.

The missing records were never fully recovered. Some of what should have been in the minute book was reconstructed well enough, through the registry filings and the accountant's files, to support the sale and satisfy Pratheep's own due diligence; some of it, particularly the earliest years of the corporation's history from before the accountant's current filing system began, simply was not recoverable and had to be accepted as a permanent gap in the file going forward with the new owner. Laszlo's own health situation stabilized enough over the following months that he was able to close out the rest of the estate, the bank accounts and the modest personal property, at a more ordinary pace. The shares were the one asset in the file where the clock genuinely worked against him from the very first week.

What you can learn from this